Delandistrogene moxeparvovec, a gene therapy approved for the treatment of Duchenne muscular dystrophy (DMD), was found ...

One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in ...

PT Solutions Physical Therapy ("PTS"), a clinician-founded and led practice with 550 points of service in 25 states, is ...

A South Florida Water Management District python removing contractor leads a team of python-hunting veterans in the Florida ...

The change limits treatment options for veterans with gender dysphoria, who are up to 20 times more likely to experience suicidal thoughts.

Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, will present new ...

Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.

Class, Polyphosphate (polyP)-Based Therapy, Show Promise in Bypassing P2Y12 Inhibition to Restore Normal Clotting Function ...

According to investigators, there is no validated PSA-based endpoint to compare oncologic outcomes after radical prostatectomy and radiation therapy for localized prostate cancer.

Multiple presentations demonstrate that T-knife’s proprietary next-generation technologies address important challenges with current cell therapy ...